On-Demand webinar
Summary:
Over 7.3 million Americans have been infected with the SARS-CoV-2 virus, with more than 200,000 deaths.1 In the most severe COVID-19 cases patients can develop a dysregulated cytokine inflammatory response to the infection. Upon further evaluation, IL-6 is thought to be a central regulator of the cytokine response and cytokine storm.
In this Webinar, you will learn about the challenges healthcare providers face treating patients with COVID-19 and the dangers of the Cytokine Storm response. And learn how elevated IL-6 is associated with a higher risk of progressing to a severe disease in COVID-19 patients.
Speaking on these findings, Dr. John Mitsios, Ph.D. senior clinical consultant at Siemens Healthineers, will help you:
- Identify the implications of cytokine storm in severe COVID-19 disease.
- Recognize IL-6 as the central regulator of the cytokine response and cytokine storm.
- Describe the association of elevated IL-6 levels with higher risk of progressing to severe disease in COVID-19 patients.
Speaker:
Dr. John Mitsios, Ph.D.
Clinical Consultant, Siemens Healthineers
Dr. Mitsios graduated from the University of Ioannina, Greece with a PhD in Chemistry. Upon completion of his doctoral thesis, he then went on to complete a post-doctoral fellowship at the University of California, San Diego under the mentorship of Dr. Sanford J. Shattil. Dr. Mitsios then transitioned to the world of Clinical Chemistry and completed a fellowship at Washington University in St. Louis, MO. His primary research interest throughout his education and training has been in coagulation, with an emphasis on platelet function and biology. Recently Dr. Mitsios joined Siemens-Healthineers as a clinical consultant as part of the Scientific and Clinical Affairs team. In addition, Dr. Mitsios has co-authored 20 peer-reviewed articles and 3 book chapters.
